Ironwood Pharmaceuticals (IRWD) Selling, General & Administrative (2010 - 2026)
Powered by 
Analysis
Ironwood Pharmaceuticals (IRWD) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.04 Bn | 198.05 Bn | 7.24 Bn | 1.75 Bn |
| 2 | Gilead Sciences | 181.35 Bn | 178.17 Bn | 6.22 Bn | 1.92 Bn |
| 3 | Vertex Pharmaceuticals | 132.22 Bn | 124.37 Bn | 2.84 Bn | 582.20 Mn |
| 4 | Regeneron Pharmaceuticals | 82.94 Bn | 74.94 Bn | 3.93 Bn | 662.10 Mn |
| 5 | Argenx Se | 61.53 Bn | 56.34 Bn | 1.37 Bn | -417.00 Mn |
| 6 | Moderna | 54.25 Bn | 49.11 Bn | 52.00 Mn | 216.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.41 Bn | 31.10 Bn | 992.69 Mn | 347.92 Mn |
| 8 | Biogen | 31.19 Bn | 29.91 Bn | 1.96 Bn | 709.70 Mn |
| 9 | Roivant Sciences | 30.10 Bn | 30.10 Bn | 1.16 Mn | 165.53 Mn |
| 10 | Ironwood Pharmaceuticals | 674.06 Mn | 594.93 Mn | - | 11.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.31 Mn |
| Mar 31, 2026 | 12.03 Mn |
| Dec 31, 2025 | 19.29 Mn |
| Sep 30, 2025 | 21.91 Mn |
| Jun 30, 2025 | 16.80 Mn |
| Mar 31, 2025 | 24.26 Mn |
| Dec 31, 2024 | 33.59 Mn |
| Sep 30, 2024 | 36.11 Mn |
| Jun 30, 2024 | 36.96 Mn |
| Mar 31, 2024 | 37.61 Mn |
| Dec 31, 2023 | 38.67 Mn |
| Sep 30, 2023 | 36.05 Mn |
| Jun 30, 2023 | 52.48 Mn |
| Mar 31, 2023 | 31.12 Mn |
| Dec 31, 2022 | 28.39 Mn |
| Sep 30, 2022 | 28.62 Mn |
| Jun 30, 2022 | 30.12 Mn |
| Mar 31, 2022 | 28.86 Mn |
| Dec 31, 2021 | 28.69 Mn |
| Sep 30, 2021 | 27.74 Mn |